Stanley K. Lau, associated with Cardio Diagnostics Holdings Inc. [CDIO], completed a purchase of the company's common stock on January 31, 2024. The transaction involved the acquisition of 917 shares at a price of $2.18 per share. Following this transaction, Lau's direct holdings in the company's common stock increased to a total of 91,522 shares. The transaction is classified as an exercise or conversion of derivative security, and the total value of the acquired shares amounts to $1,999.06.
Stanley K. Lau, associated with Cardio Diagnostics Holdings Inc. [CDIO], completed a purchase of the company's common stock on January 31, 2024. The transaction involved the acquisition of 917 shares at a price of $2.18 per share. Following this transaction, Lau's direct holdings in the company's common stock increased to a total of 91,522 shares. The transaction is classified as an exercise or conversion of derivative security, and the total value of the acquired shares amounts to $1,999.06.
与Cardio Diagnostics Holdings Holdings Inc. [CDIO] 相关的Stanley K.Lau于2024年1月31日完成了对该公司普通股的收购。该交易涉及以每股2.18美元的价格收购917股股票。在这笔交易之后,刘在公司普通股中的直接持股量增加到总共91,522股。该交易被归类为衍生证券的行使或转换,收购股票的总价值为1,999.06美元。
与Cardio Diagnostics Holdings Holdings Inc. [CDIO] 相关的Stanley K.Lau于2024年1月31日完成了对该公司普通股的收购。该交易涉及以每股2.18美元的价格收购917股股票。在这笔交易之后,刘在公司普通股中的直接持股量增加到总共91,522股。该交易被归类为衍生证券的行使或转换,收购股票的总价值为1,999.06美元。